Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print January 24, 2007, doi:10.1212/01.wnl.0000254458.17630.c5)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000254458.17630.c5v1
68/12/916    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuchs, J.
Right arrow Articles by Farrer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchs, J.
Right arrow Articles by Farrer, M. J.
Received July 28, 2006
Accepted November 21, 2006

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication

J. Fuchs MD, C. Nilsson MD, PhD, J. Kachergus BSc, M. Munz MD, E.-M. Larsson MD, B. Schüle MD, J. W. Langston MD, F. A. Middleton PhD, O. A. Ross PhD, M. Hulihan MPH, T. Gasser MD*, and M. J. Farrer PhD

From the Hertie Institute for Clinical Brain Research (J.F., M.M., T.G.), Department of Neurodegenerative Diseases, Center for Neurology, University of Tübingen, Germany; Department of Clinical Medicine (C.N., E.-M.L.), Divisions of Geriatric Psychiatry (C.N.) and Diagnostic Radiology (E.-M.L.), Lund University, Sweden; Department of Neuroscience (J.K., O.A.R., M.H., M.J.F.), Mayo Clinic College of Medicine, Jacksonville, FL, Parkinson’s Institute (B.F., J.W.L.), Sunnyvale, CA, and Center for Neuropsychiatric Genetics (F.A.M.), Microarray Core Facility, SUNY Upstate Medical University, Syracuse, NY.


* To whom correspondence should be addressed. E-mail: thomas.gasser{at}med.uni-tuebingen.de.

Abstract--Background: The "Lister family complex," an extensive Swedish family with autosomal dominant Parkinson disease, was first described by Henry Mjönes in 1949. On the basis of clinical, molecular, and genealogic findings on a Swedish and an American family branch, we provide genetic evidence that explains the parkinsonism in this extended pedigree. Methods: Clinical methods included a detailed neurologic exam of the proband of the Swedish family branch, MRI, and ([123]I)-beta-CIT SPECT imaging. Genomic analysis included {alpha}-synuclein sequencing, SNCA real-time PCR dosage, chromosome 4q21 microsatellite analysis, and high-resolution microarray genotyping. The geographic origin and ancestral genealogy of each pedigree were researched in the medical literature and Swedish Parish records. Results: The proband of the Swedish family branch presented with early dysautonomia followed by progressive parkinsonism suggestive of multiple system atrophy. Molecular analysis identified a genomic duplication of <0.9 Mb encompassing {alpha}-synuclein and multimerin 1 (SNCA-MMRN1), flanked by long interspersed repeat sequences (LINE L1). Microsatellite variability within the genomic interval was identical to that previously described for a Swedish American family with an {alpha}-synuclein triplication. Subsequent genealogic investigation suggested that both kindreds are ancestrally related to the Lister family complex. Conclusion: Our findings extend clinical, genetic, and genealogical research on the Lister family complex. The genetic basis for familial parkinsonism is an SNCA-MMRN11 multiplication, but whereas SNCA-MMRN1 duplication in the Swedish proband (Branch J) leads to late-onset autonomic dysfunction and parkinsonism, SNCA-MMRN1 triplication in the Swedish American family (Branch I) leads to early-onset Parkinson disease and dementia.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K. D. Cronin, D. Ge, P. Manninger, C. Linnertz, A. Rossoshek, B. M. Orrison, D. J. Bernard, O. M.A. El-Agnaf, M. G. Schlossmacher, R. L. Nussbaum, et al.
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human {alpha}-synuclein in transgenic mouse brain
Hum. Mol. Genet., September 1, 2009; 18(17): 3274 - 3285.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Lesage and A. Brice
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Hum. Mol. Genet., April 15, 2009; 18(R1): R48 - R59.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
U Wullner, I Schmitt, M Kammal, H A Kretzschmar, and M Neumann
Definite multiple system atrophy in a German family
J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 449 - 450.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yonetani, T. Nonaka, M. Masuda, Y. Inukai, T. Oikawa, S.-i. Hisanaga, and M. Hasegawa
Conversion of Wild-type {alpha}-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant
J. Biol. Chem., March 20, 2009; 284(12): 7940 - 7950.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Gasser
Genomic and proteomic biomarkers for Parkinson disease
Neurology, February 17, 2009; 72(7_Supplement_2): S27 - S31.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
P. Ibanez, S. Lesage, S. Janin, E. Lohmann, F. Durif, A. Destee, A.-M. Bonnet, C. Brefel-Courbon, S. Heath, D. Zelenika, et al.
{alpha}-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism: Frequency, Phenotype, and Mechanisms
Arch Neurol, January 1, 2009; 66(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. R. Troiano, C. Cazeneuve, I. Le Ber, A. -M. Bonnet, S. Lesage, A. Brice, B. S. Jeon, T. B. Ahn, and S. S. Park
{alpha}-Synuclein gene duplication is present in sporadic Parkinson disease
Neurology, October 14, 2008; 71(16): 1295 - 1295.
[Full Text] [PDF]


Home page
FASEB J.Home page
J. Fuchs, A. Tichopad, Y. Golub, M. Munz, K. J. Schweitzer, B. Wolf, D. Berg, J. C. Mueller, and T. Gasser
Genetic variability in the SNCA gene influences {alpha}-synuclein levels in the blood and brain
FASEB J, May 1, 2008; 22(5): 1327 - 1334.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
T. Ikeuchi, A. Kakita, A. Shiga, K. Kasuga, H. Kaneko, C.-F. Tan, J. Idezuka, K. Wakabayashi, O. Onodera, T. Iwatsubo, et al.
Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Arch Neurol, April 1, 2008; 65(4): 514 - 519.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Obi, K. Nishioka, O. A. Ross, T. Terada, K. Yamazaki, A. Sugiura, M. Takanashi, K. Mizoguchi, H. Mori, Y. Mizuno, et al.
CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Neurology, January 15, 2008; 70(3): 238 - 241.
[Full Text] [PDF]


Home page
NeurologyHome page
J. Theuns and C. Van Broeckhoven
{alpha}-Synuclein gene duplications in sporadic Parkinson disease
Neurology, January 1, 2008; 70(1): 7 - 9.
[Full Text] [PDF]


Home page
NeurologyHome page
C. Klein and M. G. Schlossmacher
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Neurology, November 27, 2007; 69(22): 2093 - 2104.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Winkler, J. Hagenah, S. Lincoln, M. Heckman, K. Haugarvoll, K. Lohmann-Hedrich, V. Kostic, M. Farrer, and C. Klein
{alpha}-Synuclein and Parkinson disease susceptibility
Neurology, October 30, 2007; 69(18): 1745 - 1750.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.